AACR: Accelerated Aging Linked to Incidence of Early-Onset Cancer
By Elana Gotkine HealthDay Reporter
TUESDAY, April 9, 2024 -- Accelerated aging (AA) is increasing and is associated with an increased incidence of early-onset solid tumors, according to a study presented at the annual meeting of the American Association for Cancer Research, held from April 5 to 10 in San Diego.
Ruiyi Tian, M.P.H., from the Washington University School of Medicine in St. Louis, and colleagues examined the potential link between AA and onset of cancer at younger ages in a prospective cohort of 148,724 participants aged 37 to 54 years from the U.K. Biobank. By standardizing the residuals of biological age after regression against chronological age, AA was quantified.
The researchers found that 3,190 early-onset solid cancer cases occurred across 1,707,115 person-years. There was strong evidence seen for an incremental risk for AA in successive birth cohorts, after controlling for chronological age. Individuals born in 1965 and after had a 17 percent higher risk for AA compared with those born in 1950 to 1954. AA was associated with an increased risk for early-onset tumors after multivariable adjustment (hazard ratio per standard deviation, 1.08), driven by lung, gastrointestinal, and uterine cancers (hazard ratios, 1.42, 1.22, and 1.36, respectively). Those in the highest versus the lowest tertile of AA had a significantly increased risk for early-onset lung cancer, gastrointestinal cancer, and uterine cancer (hazard ratios, 2.02, 1.62, and 1.83, respectively). The associations were weaker for late-onset lung cancer, gastrointestinal cancer, and uterine cancer.
"If validated, our findings suggest that interventions to slow biological aging could be a new avenue for cancer prevention, and screening efforts tailored to younger individuals with signs of accelerated aging could help detect cancers early," Tian said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.